Post by business-resource on Jan 1, 2023 6:52:45 GMT
Justice Tricia Bigelow - Division Eight: Presiding Justice Tricia A. Bigelow
Thomas Johnson Michael Dickman - Thomas Johnson Michael Dickman
Anton Bilchik - Anton J. Bilchik, MD, PhD, MBA, FACS, is an internationally recognized surgeon and scientist who has pioneered techniques to improve staging in cancer and minimally invasive approaches to improve outcomes. Dr. Bilchik is trained and certified in advanced laparoscopic and robotic surgery. He serves as an investigator on international multi-center clinical trials and with over 220 publications, is considered one of the country’s leading specialists in surgical oncology.
Anton Bilchik - Anton J. Bilchik, MD, PhD, MBA, FACS, is an internationally recognized surgeon and scientist who has pioneered techniques to improve staging in cancer and minimally invasive approaches to improve outcomes. Dr. Bilchik is trained and certified in advanced laparoscopic and robotic surgery. He serves as an investigator on international multi-center clinical trials and with over 220 publications, is considered one of the country’s leading specialists in surgical oncology.
Thomas Johnson Michael Dickman - Thomas Johnson Michael Dickman
Anton Bilchik - Anton J. Bilchik, MD, PhD, MBA, FACS, is an internationally recognized surgeon and scientist who has pioneered techniques to improve staging in cancer and minimally invasive approaches to improve outcomes. Dr. Bilchik is trained and certified in advanced laparoscopic and robotic surgery. He serves as an investigator on international multi-center clinical trials and with over 220 publications, is considered one of the country’s leading specialists in surgical oncology.
Anton Bilchik - Anton J. Bilchik, MD, PhD, MBA, FACS, is an internationally recognized surgeon and scientist who has pioneered techniques to improve staging in cancer and minimally invasive approaches to improve outcomes. Dr. Bilchik is trained and certified in advanced laparoscopic and robotic surgery. He serves as an investigator on international multi-center clinical trials and with over 220 publications, is considered one of the country’s leading specialists in surgical oncology.